The efficacy and safety of SGLT2 inhibitors combined with ACEI/ARBs in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis

Supplementary Material 1: The risk of bias of enrolled trails according to version 2 of the Cochrane risk-of-bias tool. (A): The graph of risk of bias; (B): The summary of risk of bias. Supplementary Material 2: Forest plot of sensitivity analysis by omitting Perkovic's study. Supplementary Material 3: Forest plots of subgroup analyses according to ages, baseline HbA1c, eGFR, or SBP/DBP levels of participants.补充材料1：基于Cochrane风险偏倚工具第2版（Cochrane risk-of-bias tool）评估纳入试验的偏倚风险。(A)：偏倚风险统计图；(B)：偏倚风险汇总结果。 补充材料2：剔除Perkovic研究后的敏感性分析森林图。 补充材料3：依据受试者年龄、基线糖化血红蛋白（HbA1c）、估算肾小球滤过率（eGFR）或收缩压/舒张压（SBP/DBP）水平开展亚组分析的森林图。